Research News

Recognized for his exploration of sustainable materials, Assistant Professor Kent Zheng has been named to Forbes 30 Under 30 in Science.

For her contributions to the field of materials science, Assistant Professor Wennie Wang has received the American Physical Society’s 2025 Maria Goeppert Mayer Award.

Researchers have discovered an antibody able to neutralize all known variants of SARS-CoV-2, the virus that causes COVID-19, as well as distantly related SARS-like coronaviruses that infect other animals.

Brian Korgel, a professor in the McKetta Department of Chemical Engineering, will be the next director of the Energy Institute at The University of Texas at Austin, effective Sept. 1.

Professor Dave Allen of the Cockrell School’s McKetta Department of Chemical Engineering will receive a prestigious Eni Award, a top honor in the fields of energy and environmental research.

The most complete picture yet is coming into focus of how antibodies produced in people who effectively fight off SARS-CoV-2 work to neutralize the part of the virus responsible for causing infection. In the journal Science, researchers at The University of Texas at Austin describe the finding, which represents good news for designing the next generation of vaccines to protect against variants of the virus or future emerging coronaviruses.

People say that starting and growing a company is like giving birth and raising a child. For NwaBebé co-founders and Longhorns Texas ChE Associate Professor Lydia Contreras and Dara Chike-Obi (Law ’08, McCombs ’20) , entrepreneurship and motherhood are indeed inextricably tied. “The initial inspiration for NwaBebé was our journey into parenthood,” Chike-Obi says.

Professor Jim Chelikowsky has been awarded The Minerals, Metals, and Materials Society’s (TMS) John Bardeen Award. The award recognizes individuals who have made outstanding contributions and are leaders in the field of electronic materials.

Poor air quality where you live can increase risk for lung-related diseases like asthma and COPD, but Texas ChE research indicates it can even increase risk for obesity.

Texas ChE Research Associate Jason Lavinder made key contributions to the country’s first peer-reviewed study on a promising COVID-19 treatment.